Historique de carrière de Kjell Rensfeldt
Anciens postes connus de Kjell Rensfeldt
Sociétés | Poste | Début | Fin |
---|---|---|---|
MOBERG PHARMA AB | Directeur Technique/Scientifique/R&D | 01/01/2007 | 13/08/2018 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - | - |
BIOGEN INC. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Suède | 3 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MOBERG PHARMA AB | Health Technology |
BIOGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
- Bourse
- Insiders
- Kjell Rensfeldt
- Expérience